AFT Pharmaceuticals (NZSE:AFT) Tariff Resilience Score: 0/10 (As of Jul. 06, 2026)


NZSE:AFT AFT Pharmaceuticals Ltd NZSE:AFT
95 GF Score
Price NZ$3.71
GF Value NZ$4.17
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is AFT Pharmaceuticals Tariff Resilience Score?

AFT Pharmaceuticals has the Tariff Resilience Score of 0, which implies that the company might have .

AFT Pharmaceuticals has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes AFT Pharmaceuticals might have .

AFT Pharmaceuticals  (NZSE:AFT) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

AFT Pharmaceuticals Tariff Resilience Score Related Terms

NZSE:AFT
95GF Score
AFT Pharmaceuticals Ltd NZSE:AFT
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is AFT Pharmaceuticals (NZSE:AFT) Overvalued in 2026?

Based on GuruFocus' analysis, AFT Pharmaceuticals stock appears to be undervalued. The current stock price of NZ$3.71 is trading 11% below its estimated GF Value™ of NZ$4.17. GuruFocus considers AFT Pharmaceuticals to be Modestly Undervalued.

Key valuation signals for NZSE:AFT:

  • Tariff Resilience Score: 0
  • GF Value™: NZ$4.17 vs. price of NZ$3.71 (11% below fair value)
  • GF Score™: 95/100 with 3 warning signs

No single metric tells the full story. See the NZSE:AFT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AFT Pharmaceuticals Business Description

Other Exchanges AFP:Australia
Address 129 Hurstmere Road, Level 1, Takapuna, Auckland, NTL, NZL, 0622
AFT Pharmaceuticals Ltd is a pharmaceutical distributor and developer of pharmaceutical intellectual property. Some of the products of the organization are Maxigesic dose forms, Capsaicin creams, Crystaderm, Kiwisoothe, Micolette, and others. The group has four operating segments based on geographical location being Australia, New Zealand, Asia, and the Rest of the world. It generates the majority of the revenue from Australia, which includes the sales and distribution activity relating to the Australian market.
95GF Score

Get the complete analysis for NZSE:AFT

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NZ$3.71
Price
NZ$4.17
GF Value